Protection against experimental nervous system autoimmune diseases by a human immunodeficiency virus-1 Tat peptide-based polyvalent vaccine

Journal of Neuroscience Research

Volumn 46, Issue 2, 1996, Pages 258-262

  Schluesener, Hermann J ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

autoimmune diseases; Tat peptide; toolbox101 peptide vaccine

Indexed keywords

AUTOANTIGEN; ENCEPHALITOGENIC PROTEIN; EPITOPE; FREUND ADJUVANT; HYBRID PROTEIN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; MYELIN BASIC PROTEIN; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; SYNTHETIC DNA; TRANSACTIVATOR PROTEIN; VACCINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG THERAPY; GENE DELETION; HISTOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR CLONING; NEURITIS; NEUROLOGIC DISEASE; NONHUMAN; PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN INDUCTION; PROTEIN PURIFICATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UVEORETINITIS; VACCINATION;

EID: 0029926506     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19961015)46:2<258::AID-JNR14>3.0.CO;2-Z     Document Type: Article

References (21)

1. Al-Sabbagh A, Miller A, Santos LM, Weiner HL (1994): Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur J Immunol 24:2104-2109.
2. Alvord EC, Shaw CM, Hruby S, Kies MW (1979): Has myelin basic protein received a fair trial in the treatment of multiple sclerosis? Ann Neurol 6:461-468.
3. 37-72 protein-derived peptide. Biochem Biophys Res Commun 194:876-884
4. Bitar DM, Whitacre CC (1988): Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol 112:364-370.
5. 37-72 protein after modification with biotin. Anal Biochem 227:168-175.
6. Finkelman FD (1995): Relationship among antigen presentation, cytokines, immune deviation, and autoimmune disease. J Exp Med 182:279-282.
7. Gaulam AM (1995): Self and non-self peptides treat autoimmune encephalomyelitis: T cell anergy or competition for major histocompatibility complex class II binding? Eur J Immunol 25:2059-2063.
8. Could KE, Swanborg RH (1993): T and B cell responses to myelin basic protein and encephalitogenic epitopes. J Neuroimmunol 46:193-198.
9. Gregorian SK, Clark L, Heber-Katz E, Amento EP, Rostami A (1993): Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis. Cell Immunol 150:298-310.
10. Higgins PJ, Weiner HL (1988): Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140:440-445.
11. Inoue H, Takeuchi T, Tanaka M, Usui S, Taguchi O (1994): Analysis of the uveitogenic determinant in repeat structure of retinal interphotoreceptor retinoid-binding protein (IRBP). Clin Exp Immunol 97:219-225.
12. Levine S, Hoenig EM, Kies MW (1968): Allergic encephalomyelitis: Passive transfer prevented by the encephalitogen. Science 161:1155-1157.
13. Lisak RP, Zweiman B, Dzida L, Rosenblum F, Rorke LB, Barger G (1980): In vitro response to basic protein in experimental allergic encephalomyelitis: Effect of pretieatment with basic protein in incomplete adjuvant. Cell Immunol 52:443-450.
14. Liu GY, Wraith DC (1995): Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice - Implications for autoimmunity. Int Immunol 7:1255-1263.
15. Mor F, Cohen IR (1995): Pathogenicity of T cells responsive to diverse cryptic epitopes of myelin basic protein in the Lewis rat. J Immunol 155:3693-3699.
16. Racke MK, Critchfield JM, Quigley L, Cannella B, Raine CS, McFarland HF, Leonardo MJ (1996): Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Ann Neurol 39:46-56.
17. Shaw CM, Fahlberg WJ, Kies MW, Alvord EC (1960): Suppression of experimental allergic encephalomyelitis in guinea pigs by encephalitogenic proteins extracted from homologous brain. J Exp Med 111:171-180.
18. Singh VK, Kalra HK, Yamaki K, Shinohara T (1992): Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide. Cell Immunol 139:81-90.
19. 37-72 protein and vitronectin. J Cell Biol 121:461-468.
20. 37-72 protein and its 90-kDa cell surface binding protein. J Biol Chem 268:5279-5284.
21. Zhang XM, Esch TR, Clark L, Gregorian S, Rostami A, Otvos L, Heber-Katz E (1994): Neuritogenic Lewis rat T cells use Tcrb chains that include a new Tcr-V8 family member. Immunogenetics 40:266-270.